검색옵션 상세검색
국내 의과학 학술논문 상세

Experimental Neurobiology. 2020 Dec; 29 (6): 8342415. doi: 10.5607/en20024

Intranasal Administration of Melanin-Concentrating Hormone Reduces Stress-Induced Anxiety- and Depressive-Like Behaviors in Rodents

Ju-Young Oh , Quan Feng Liu , Cai Hua , Ha Jin Jeong , Jae-Hwan Jang , Songhee Jeon , Hi-Joon Park

  • Abstract

    Major depressive disorder is a complex neuropsychiatric disorder with few treatment options. Non-targeted antidepressants have low efficacy and can induce series of side effects. While a neuropeptide, melanin-concentrating hormone (MCH), is known to exhibit regulator of affective state, no study to date has assessed the anti-depressive effects of MCH in a stress-induced depression model. This study aimed to evaluate the pharmacological effects of intranasal administration of MCH on depression-related behavior in stressed rats and mice. Using a number of behavioral tests, we found that MCH treatment significantly decreased anxiety- and depressive-like behaviors induced by stress. Notably, the effects of MCH were equivalent to those of fluoxetine. MCH treatment also restored the activity of the mammalian target of rapamycin (mTOR) signaling pathway and normalized the levels of synaptic proteins, including postsynaptic density 95, glutamate receptor 1, and synapsin 1, which were all downregulated by stress. Interestingly, the protective effects of MCH were blocked by the mTOR inhibitor, rapamycin. These results suggest that MCH exhibits antidepressant properties by modulating the mTOR pathway. Altogether, this study provides an insight into the molecular mechanisms involved in the antidepressant-like effects of MCH, thereby paving the way for the future clinical application of MCH.

  • Keywords

  • References

    more references

    1. American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders: DSM-5. 5th ed. AmericanPsychiatric Association, Arlington.

    Article

    2. World Health Organization (2008) The global burden of disease: 2004 update. World Health Organization, Geneva.

    3. Young EA, Kotun J, Haskett RF, Grunhaus L, Greden JF, Watson SJ, Akil H (1993) Dissociation between pituitary and adrenal suppression to dexamethasone in depression. Arch GenPsychiatry 50:395-403.

    Article | PubMed

    4. Kalia M (2005) Neurobiological basis of depression: an update. Metabolism 54(5 Suppl 1):24-27.

    Article | PubMed

    5. Berton O, Nestler EJ (2006) New approaches to antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci7:137-151.

    Article | PubMed

    6. Monti JM (2010) The role of dorsal raphe nucleus serotonergic and non-serotonergic neurons, and of their receptors,in regulating waking and rapid eye movement (REM) sleep.Sleep Med Rev 14:319-327.

    Article | PubMed

    7. Olivier B (2015) Serotonin: a never-ending story. Eur J Pharmacol 753:2-18.

    Article | PubMed

    8. Torterolo P, Scorza C, Lagos P, Urbanavicius J, Benedetto L,Pascovich C, López-Hill X, Chase MH, Monti JM (2015)Melanin-concentrating hormone (MCH): role in REM sleepand depression. Front Neurosci 9:475.

    Article | PubMed | PMC

    9. Kawauchi H, Kawazoe I, Tsubokawa M, Kishida M, Baker BI(1983) Characterization of melanin-concentrating hormonein chum salmon pituitaries. Nature 305:321-323.

    Article | PubMed



G
N
I
D
A
O
L